Accessibility Menu
Xcorporeal logo

Xcorporeal(OTC) XCRP

Current Price$0.00
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1994)-100%
5 Year-100%
1 Year-99%
1 Month+0%
Xcorporeal last closing stock price
MetricPriceDate
Last closeUSD 0.002026-03-04
Xcorporeal stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-02-10
1 month+0%USD 0.002025-10-30
3 month+0%USD 0.002025-10-30
Year to date+0%USD 0.002025-10-30
1 year-99%USD 0.002024-10-16
3 year+0%USD 0.002023-02-28
5 year-99.99%USD 0.012021-02-18
Since inception-100%USD 179.211994-07-28

Xcorporeal Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3.69 (High)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

XCRP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xcorporeal

Xcorporeal, Inc. is a healthcare company that previously focused on developing extra-corporeal platform technology for medical devices. The company is currently in the process of winding down and dissolving its operations.

Products and Services
  • Previously developed medical devices for organ function replacement
  • Focused on extra-corporeal platform technology
  • Engaged in the management of corporate assets during liquidation
Growth Outlook
  • Company established a Liquidating Trust for asset management
  • Transitioning from operational activities to asset liquidation
  • Focus on efficient management of remaining resources
Financial Highlights
  • Market capitalization stands at $1,515
  • Current ratio is 0.83, indicating liquidity challenges
  • Cash per share is $0.23, reflecting available resources
Xcorporeal, Inc. has transitioned from a medical device innovator to a company focused on asset liquidation. The establishment of the Liquidating Trust signifies a structured approach to managing remaining resources. The current financial metrics indicate liquidity challenges, with a current ratio of 0.83, suggesting the need for careful management of assets during this winding-down phase. The cash per share of $0.23 provides a glimpse into the available resources as the company navigates its final stages.
AI Generated • Jul 1, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Lake Forest, CA, US

XCRP Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-348.57%

Return on Capital

N/A

Return on Assets

-528.31%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

15.15M

Volume

1

Avg. Volume

0

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$31.89M

EBITDA

-$22.88M

Operating Cash Flow

-$12.74M

Capital Expenditure

-$175.30K

Free Cash Flow

-$12.91M

Cash & ST Invst.

$3.36M

Total Debt

$0.00

Xcorporeal Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MLTOMEDirect Latino, Inc.
$0.00+0.00%
GNRSThe Greenrose Holding Company Inc.
$0.00-50.00%
INTPIntegrated Pharmaceuticals, Inc.
$0.00+0.00%
QMEDQMed, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
NOKNokia
$9.73-0.05%
AALAmerican Airlines Group
$13.56-0.08%
TAT&T
$22.96-0.00%

Questions About XCRP

What is the current price of Xcorporeal?

Xcorporeal is trading at $0.00 per share.

What is the 52-week range for Xcorporeal?

Over the past 52 weeks, Xcorporeal has traded between $0.00 and $0.00.

How much debt does Xcorporeal have?

Xcorporeal total debt is unavailable.

How much cash does Xcorporeal have on hand?

Xcorporeal does not have cash on hand data available.

What is Xcorporeal’s dividend yield?

Xcorporeal does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services